(Q31144410)

English

Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program

scientific article

Statements

Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program (English)
0 references
1 February 2008
31 Suppl 2

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit